AYRTN announces that the shareholding of Public Investcom Corporation and Bidvest of South Africa in Adcock Ingram Holdings has increased from 19% to 22% and 4% to 34.5% respectively.
Subsequent to this development, the Chairman of Adcock, Dr. Khotso Mokhele has resigned and has been replaced with Mr. Brian Joffe, Chief Executive Officer of Bidvest.
Again, the Managing Director of Adcock, Mr. Jonathan Louw has resigned and has been replaced with Mr. Kevin Wakeford.
The financial year of Adcock has also been changed from October – September to July – June.
To ensure consistency with the financial reporting requirements of Adcock, the financial year of Ayrton Drug Manufacturing Ltd has as well been changed from October – September to July – June and same was approved by shareholders at the recently held Annual General Meeting on Friday 1st August, 2014.
Issued at Accra, this 1st
day of September, 2014.